• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Saladax Biomedical

edit

Saladax Biomedical is a commercial stage developer of 5-FU diagnostic assays for the oncology market. The company’s products span all stages of development and address a variety of therapeutic areas, with an initial focus in oncology.

Recent Milestones

edit

• 
  Saladax Biomedical received $22.4M in Private Equity funding. (3/5/13)
  Posted 3/5/13 at 4:28pm via finsmes.com
• 
  Saladax Biomedical received $9M in Debt funding. (6/21/11)
  Posted 6/21/11 at 8:07pm via genomeweb.com
• 
  Saladax Biomedical received $8.4M in Series C funding. (3/30/10)
  Posted 3/30/10 at 6:54pm via onbiovc.com
• 
  Saladax Biomedical added Caleb Winder as Board Observer.
  Posted 8/6/12 at 8:11am

Videos

Screenshots

edit

Sources

1. Saladax Biomedical, Inc.: Series C $8.4M (onbiovc.com) [edit]
2. Saladax Secures $9M Loan Facility from GE Capital (genomeweb.com) [edit]
3. Saladax Biomedical Receives $22.4M Strategic Equity Investment (finsmes.com) [edit]